Top Cancer Stocks in South Korea
Browse the largest South Korea companies in the world ranked by their Market Capitalization. Global Cancer Companies in South Korea market cap is $6.41B.
25 Aug 2024, 14:19 UTC
Companies: 16
🇰🇷1 |  | $229.87 | 3.05% | 2.92B | -13.86% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇰🇷2 |  | $23.78 | 5.70% | 1.14B | 26.76% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷3 |  | $34.88 | -2.01% | 993.15M | -43.73% | Underperform S&P500 YTD Benchamark | 🦾 AI | - |
🇰🇷4 |  | $1.76 | 0.22% | 243.78M | -3.53% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇰🇷5 |  | $11.42 | -0.59% | 230.93M | -33.93% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷6 |  | $5.39 | -4.03% | 223.41M | -28.60% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷7 |  | $2.36 | 0.81% | 166.12M | -48.26% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷8 |  | $6.11 | -0.12% | 115.05M | -3.46% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷9 |  | $6.48 | 6.44% | 88.21M | 92.17% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷10 |  | $3.13 | 3.62% | 87.35M | -4.49% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷11 |  | $4.79 | -2.01% | 66.42M | -46.55% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷12 |  | $5.04 | 0.00% | 39.43M | N/A | S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷13 |  | $1.09 | 1.12% | 36.16M | -45.33% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷14 |  | $0.54 | -0.97% | 28.53M | -40.33% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷15 |  | $1.40 | -2.32% | 24.71M | -13.10% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷16 |  | $2.08 | -2.47% | 15.19M | -17.61% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
